Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial

Int J Cardiol. 2015 Jan 20:179:348-50. doi: 10.1016/j.ijcard.2014.11.034. Epub 2014 Nov 11.

Authors

Annelise C Costanza¹, Samuel D Moscavitch², Hugo C C Faria Neto³, Evandro T Mesquita¹

Affiliations

¹ Federal Fluminense University, Hospital Universitário Antonio Pedro, Post-Graduation Program in Cardiovascular Sciences, Niteroi, Brazil.
² Oswaldo Cruz Institute (IOC/Fiocruz), Laboratory of Immunopharmacology, Rio de Janeiro, RJ, Brazil. Electronic address: samuel.moscavitch@ioc.fiocruz.br.
³ Oswaldo Cruz Institute (IOC/Fiocruz), Laboratory of Immunopharmacology, Rio de Janeiro, RJ, Brazil.

PMID: 25464484
DOI: 10.1016/j.ijcard.2014.11.034

No abstract available

Keywords: Failure; Heart; Inflammation; Microbiota; Probiotic; Systolic.

Publication types

Controlled Clinical Trial
Letter
Randomized Controlled Trial

MeSH terms

Double-Blind Method
Heart Failure / diagnosis*
Heart Failure / diet therapy*
Humans
Pilot Projects
Probiotics / administration & dosage*
Saccharomyces*